Britain must vaccinate two million a week to prevent a third COVID-19 wave: Study

Britain must vaccinate two million a week to prevent a third COVID-19 wave: Study

By Administrator_India

Capital Sands

Britain must vaccinate two million people a week to avoid a third wave of the coronavirus outbreak, a study by the London School of Hygiene and Tropical Medicine (LSHTM) has concluded.

The UK has had more than 71,000 deaths from the coronavirus and has recorded over 2.3 million cases of COVID-19 infections as of late Monday, according to a Reuters tally.

“The most stringent intervention scenario with tier 4 England-wide and schools closed during January and 2 million individuals vaccinated per week, is the only scenario we considered which reduces peak ICU burden below the levels seen during the first wave”, the study said.

“In the absence of substantial vaccine roll-out, cases, hospitalisations, ICU admissions and deaths in 2021 may exceed those in 2020.”

An accelerated uptake of two million vaccinated per week “is predicted to have a much more substantial impact”, it added https://bit.ly/3o9l2MJ. The study has yet to be peer-reviewed.

Prime Minister Boris Johnson and his scientific advisers have said a variant of the coronavirus, which could be up to 70% more transmissible, was spreading rapidly in Britain, although it is not thought to be more deadly or to cause more serious illness.

That prompted tight social mixing restrictions measures for London and southeast England, while plans to ease curbs over Christmas across the nation were dramatically scaled back or scrapped altogether.

Media reports over the weekend said that the United Kingdom will roll out the Oxford-AstraZeneca COVID-19 vaccine from Jan. 4, with its approval by the country’s medical regulator expected within days.

Earlier this month, the United Kingdom became the first country in the world to roll out the vaccine made by Pfizer and BioNTech.

The British government said on Thursday that 600,000 people in the United Kingdom have received the first dose of the Pfizer-BioNTech COVID-19 vaccine since inoculations began.

Related Posts
New CDC study shows major drop in efficacy of booster shots after fourth month:
COVID-19 vaccine booster doses

The US Centres of Disease Control and Prevention (CDC) on Friday said that the efficacy of the third doses of Read more

COVAX Targets 70% COVID-19 Immunization Coverage By Mid-2022
The Brihanmumbai Municipal Corporation (BMC) on Thursday said the COVID-19 patients with mild symptoms can stay in home

Geneva, Switzerland:  Amid possible need for variant-specific vaccines, changes to vaccination policies, country preference for some products over others, the Read more

India’s daily Covid-19 cases fall to 120,529, active cases dip to over 1.5 million
Covid update: At 92,596, new cases go up slightly; positivity rate below 5%

By Administrator_India Capital Sands India’s daily caseload of the coronavirus disease (Covid-19) witnessed a further dip, as 120,529 cases were Read more

PM Modi kicks off third phase of vaccination, takes first jab of Covaxin

By Administrator_India Capital Sands Prime Minister Narendra Modi on Monday set the ball rolling for the third phase of vaccination with an early-morning jab Read more

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x